Jane Street’s Inovio Pharmaceuticals INO Stock Holding History

Jane Street’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71K	Buy	+40,800	New	+$67.2K	﹤0.01%	10814
2023 Q1	–	Sell	-2,950	Closed	-$55.2K	–	9446
2022 Q4	$55.2K	Sell	2,950 -1,583	-35%	-$35.9K	﹤0.01%	8331
2022 Q3	$94K	Buy	4,533 +2,775	+158%	+$71K	﹤0.01%	8675
2022 Q2	$37K	Sell	1,758 -10,775	-86%	-$304K	﹤0.01%	9000
2022 Q1	$540K	Sell	12,533 -6,234	-33%	-$281K	﹤0.01%	7326
2021 Q4	$1.12M	Buy	18,767 +2,842	+18%	+$228K	﹤0.01%	5657
2021 Q3	$1.37M	Sell	15,925 -242	-1%	-$24.3K	﹤0.01%	5280
2021 Q2	$1.8M	Sell	16,167 -37,266	-70%	-$3.58M	﹤0.01%	4526
2021 Q1	$5.95M	Sell	53,433 -3,092	-5%	-$407K	﹤0.01%	2155
2020 Q4	$6M	Sell	56,525 -12,292	-18%	-$1.64M	﹤0.01%	1919
2020 Q3	$9.58M	Sell	68,817 -75,700	-52%	-$15.8M	0.01%	1245
2020 Q2	$46.7M	Buy	144,517 +114,575	+383%	+$18.4M	0.04%	384
2020 Q1	$2.67M	Buy	+29,942	New	+$1.85M	﹤0.01%	1725

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's INO Position: Q1 2026 in Review

Jane Street reduced its Inovio Pharmaceuticals (INO) stake by 47% in Q1 2026, selling an estimated $45.6K and leaving 30,691 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #10951.

Jane Street first reported a position in INO in Q4 2013 and has held it in 37 quarters since. The position peaked at $23.3M in Q2 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

Jane Street held 30,691 shares of Inovio Pharmaceuticals worth $53.4K as of Q1 2026.
Jane Street sold 27,698 Inovio Pharmaceuticals shares in Q1 2026, an estimated $45.6K.
Inovio Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10951 holding.
Jane Street first reported a position in Inovio Pharmaceuticals in Q4 2013 and has held it in 37 quarters since.
Jane Street's Inovio Pharmaceuticals position peaked at $23.3M in Q2 2020.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.